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Abstract
Background: Adenomyosis is a common gynecological disease, which is accompanied by a series of
immunological and neuroendocrinological changes. Nerve growth factor (NGF) plays a critical role in producing
pain, neural plasticity, immunocyte aggregation and release of inflammatory factors. This study aimed to investigate
the expression of NGF and its two receptors in uteri and dorsal root ganglia (DRG) in an adenomyosis mouse
model, as well as their relationship with the severity of adenomyosis.
Methods: Forty newborn ICR mice were randomly divided into the adenomyosis model group and control group
(n = 20 in each group). Mice in the adenomyosis model group were orally dosed with 2.7 μmol/kg tamoxifen on
days 2-5 after birth. Experiments were conducted to identify the expression of NGF- beta and its receptors, tyrosine
kinase receptor (trkA) and p75 neurotrophin receptor (p75NTR), in the uterus and DRG in four age groups (90+/-5
d, 140+/-5 d, 190+/-5 d and 240+/-5 d; n = 5 mice in each group) by western bolt, immunochemistry and real
time reverse transcription-polymerase chain reaction.
Results: Adenomyosis, which became more serious as age increased, was successfully induced in dosed ICR mice.
NGF-beta, trkA and p75NTR protein levels in the uterus and trkA mRNA levels in DRG were higher in the older
aged adenomyosis model group than those in controls (190+/-5 d and 240+/-5 d groups, P < 0.05). The expression
of NGF-beta and its receptors in the uterus increased gradually as age increased for adenomyosis mice (190+/-5 d
and 240+/-5 d, P < 0.05, compared with 90+/-5 d) but it showed little change in control mice. The mRNA level of
trkA in DRG also increased as age increased in the adenomyosis model group (190+/-5 d and 240+/-5 d, P < 0.05,
compared with 90+/-5 d) but was unchanged in controls. The mRNA level of p75NTR in DRG was not different
between the adenomyosis and control groups and was stable from young to old mice.
Conclusions: NGF- beta can be used as an indicator for the severity of adenomyosis. The gradually increasing level
of NGF- beta and its receptors while the disease becomes more severe suggests an effect of NGF- beta on
pathogenic mechanisms of adenomyosis.
Background
Adenomyosis is defined as the presence of ectopic endo-
metrial glands and stroma within the myometrium. It is
a relatively frequent endomyometrial pathology that is
found in multiparous women between 40 and 50 years
of age [1]. Approximately 2/3 of women with adeno-
myosis are symptomatic with menorrhagia and dysme-
norrhoea [2]. However, the etiology and pathogenic
mechanisms responsible for adenomyosis are poorly
understood.
An impaired neuroimmune status may be necessary
for the maintenance of adenomyosis, and it could play
an important part in the mechanism by which the
symptoms of adenomyosis are generated [3-5]. NGF was
the first neurotrophic factor to be discovered and it
plays a critical role in producing pain, neural plasticity,
immunocyte aggregation, and release of inflammatory
factors [6,7]. Several studies have suggested that abnor-
mal expression of NGF in adenomyosis and endometrio-
sis might be involved in the pathomechanism of these
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that there is an intense NGF-b immunoreactivity near
ectopic endometriotic glands [10-12]. The receptors of
NGF are high-affinity tyrosine kinase receptor (trkA)
and low-affinity p75 neurotrophin receptor (p75NTR),
and they are immunoreactive in nerve fibers that are
close to endometriotic glands and blood vessels [13-15].
A potential involvement of NGF-b in innervation and
pain occurring in endometriosis has been suggested [9].
In our previous studies, we found a higher NGF-b
expression in adenomyosis mice, which might explain
the augmented innervation and inflammation status in
the uterus [8]. Abnormal expression of the nonfunc-
tional subunit NGF-a (not the functional subunit NGF-
b) has also been detected in uteri of newborn mice,
which acquire adenomyosis in adulthood [16,17].
Discovered over 50 years ago, NGF has been exten-
sively studied in various biological systems in an attempt
to understand its role in adenomyosis. It has been
shown to play significant roles in the transmission of
physiological and pathological pain [6,7]. Transgenic
animals lacking the gene for NGF and trkA are hypoal-
gesic and are born without small diameter nociceptive
sensory neurons [18,19]. In contrast, animals that over
express NGF, or humans injected with NGF in cuta-
neous targets, have behavioral or sensorius hyperalgesia
[20,21]. The mechanism of how NGF is involved in pain
is manifold and complicated. NGF can promote the pro-
liferation of nerve fibers and improve their sensitivity.
NGF is crucial for the development of sympathetic and
small fiber sensory neurons that serve as nociceptors
[6]. It is also involved in sensitizing or exciting the
terminals of sensory nerve fibers by stimulating the
expression and release of neuropeptides [22]. NGF plays
an important role in mediating and/or regulating the
immune response. It has been proposed that NGF is
involved in the recruitment, survival, and activation of
mast cells, T cells of the Th2 phenotype, and eosinophil
infiltration [23]. By stimulating the degranulation of
mast cells, NGF can promote the release of inflamma-
tory mediators such as serotonin [24]. In addition, NGF
affects non-neurocyte proliferation, such as in myogen-
ous cells [25], cystic smooth muscle cells [26] and cor-
neal epithelial cells [27]. NGF might also participate in
stress-triggered and substance P-mediated abortion [28].
Adenomyosis is associated with recurrent and aggres-
sive pain syndrome, impaired immune status, and also
characterized by intensified weighted uterus and a high
rate of spontaneous abortion [2-4,29]. Since NGF has
abnormal expression in adenomyosis and has multiple
effects on innervation, immunoregulation, cell prolifera-
tion and production of pain, it might be involved in the
pathomechanism of adenomyosis. If NGF plays a role in
adenomyosis, NGF levels and/or its receptors might
change with the progress of this disease. To determine
this possibility, we administered tamoxifen in an adeno-
myosis mouse model. This model has an aggravated
pathogenetic condition of adenomyosis as age increases.
In addition, it is not associated with trauma and has
relatively normal sex hormone levels, which are impor-
tant for considerations because trauma and sex
hormone affect the expression of NGF [6,7,30].
In this study, we examined the relationship between
NGF-b and the severity of adenomyosis. By examining
the protein and mRNA levels of NGF and its receptors
in the uterus and dorsal root ganglia (DRG) at different
ages in adenomyosis mice, we aimed to evaluate any
changes with the severity of adenomyosis in peripheral
organs and the central nerve system.
Methods
Animals and treatments
Neonatal healthy female ICR mice (SCXK 2007-0005,
SLAC laboratory animal CO. LTD, Shanghai, China)
were housed in negative pressure isolators with a con-
trolled temperature (23-25°C) and 12 h alternating light
(8 a.m to 8 p.m) and dark cycle. To induce the adeno-
myosis mouse model, neonatal mice were orally dosed
daily on days 2 to 5 after birth (day of birth was day 1)
with 2.7 μmol/kg tamoxifen (Fudan Forward Co., Shang-
hai, China) suspended in a peanut oil/lecithin/condensed
milk mixture (2:0.2:3, by volume) at a dose volume of
5 μl/g body weight. Controls received no treatment. The
4 day estrous cycle was determined by the presence of a
characteristic vaginal discharge in the morning. ICR
Mice with at least 1 consecutive 4-day estrous cycle
were used in the present study. All experimental proce-
dures were approved by the Ethics Committee of Obste-
trics and Gynecology Hospital, Fudan University.
Euthanasia and processing of tissue
All mice were sacrificed at 5 p.m. by injecting propofol
(10 mg/kg injection, i.v.) on proestrus at age 90 ± 5, 140
±5 ,1 9 0±5a n d2 4 0±5d( n=5i ne a c hg r o u p ) .T 1 3
to L2 DRG were harvested and stored in liquid nitrogen.
Bilateral uteri were removed. After weighing, the uteri
were either frozen in liquid nitrogen or fixed in 4% neu-
tral paraformaldehyde at 4°C.
Immunohistochemistry and immunofluorescence
Formalin-fixed, 5 μm paraffin sections of mouse uterus
were dewaxed and taken to water by immersing in
xylene and gradient ethanol. Hematoxylin and eosin
(HE) staining was performed first to determine whether
there were adenomyosis nodes. Sections were then
immersed in boiling citrate buffer (pH 6.0) for 20 min.
Endogenous peroxidase activity was blocked with 3%
H2O2 for 30 min and then goat serum for 15 min.
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rabbit antibodies for NGF (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) at a dilution of 1:500, p75NTR
(Epitomics, Burlingame, CA, USA) at a dilution of 1:100,
or trkA (Epitomics, Burlingame, California, USA) at a
dilution of 1:100, at 4°C overnight. The next day, sec-
tions were incubated with biotinylated goat anti-rabbit
IgG (Zhongshan Golden Bridge Biotechnology Co., Ltd,
Beijing, China) for 15 min and then streptavidin-peroxi-
dase complex (Zhongshan Golden Bridge Biotechnology
Co., Ltd) for another 15 min at room temperature.
Staining was visualized with 3,3’-diaminobenzidine for
3 min at room temperature (Zhongshan Golden Bridge
Biotechnology Co., Ltd) and hematoxylin counter stain.
After incubated with trkA (1:100) at 4°C overnight,
some sections were incubated with biotinylated goat
anti-rabbit IgG (Boster, Wuhan, Hubei, China) for
30 min at 37°C and then streptavidin- fluorescein iso-
thiocyanate complex (Boster, Wuhan, Hubei, China) for
another 30 min at 37°C. Negative controls included
omission of the primary or secondary antibody. There
was no labeling in different groups and any of the con-
trol sections. Paraffin sections of mouse brain were used
for positive control following the instruction for the
antibody of NGF, p75NTR and trkA. Slides were exam-
ined using a radiophoto microscope (BX51, Olympus,
JP) equipped with a digital camera (DP71, Olympus, JP).
Western blot analysis
The uteri of adenomyosis and control mice were
homogenized and lysed in ice cold RIPA lysis buffer
(consisting of 50 mM Tris [pH 7.4], 150 mM NaCl, 1%
NP- 40, 0.5% sodium deoxycholate, 0.1% SDS and pro-
tease inhibitors; Beyotime, Haimen, Jiangsu, China)
with 1 mM phenylmethylsulfonyl fluoride. Each sample
containing 40 μg protein was separated by 12% SDS-
PAGE. Protein bands of samples were then electrically
transferred on PVDF membranes (Millipore, Billerica,
MA, USA) at 300 mA for 2 h. After blocking with 10%
defatted milk, membranes were incubated with rabbit
multiclonal anti-mouse NGF (Santa Cruz) at a dilution
of 1:500, monoclonal anti-mouse trkA (Epitomics) at a
dilution of 1:1000, monoclonal anti-mouse p75NTR
(Epitomics) at a dilution of 1:5000, or monoclonal
anti-mouse beta-actin (Sigma, St. Louis, MI, USA) at a
1:1000 dilution at 4°C overnight. Membranes were
then incubated with peroxidase-labeled secondary anti-
body (Jackson, West Grove, PA, USA) at a dilution of
1:5000 for 1 h. The chemiluminescent signal was
developed using BeyoECL Plus (Beyotime, Haimen,
Jiangsu, China) for 2 min and quantitated over a 5-10
min exposure using a Chemiluminescent and Fluores-
cent Imaging System (Fluochem FC2, Alpha Innotech,
San Leandro, CA, USA).
Real time reverse transcription polymerase chain reaction
(real time RT-PCR)
Total RNA from DRG (T13 to L2 together) was isolated
using TRIzol reagent (Invitrogen, Carlsbad, CA, USA).
Complementary DNA was synthesized from 1 μgR N A
using superscript II reverse transcriptase and oligo (dT)
12-18 primers (Fermentas, Glen Burnie, MD, USA).
Real-time PCR reactions were performed using a Bio-
Rad IQ5 machine (Bio-Rad, Hercules, CA, USA) and
SYBR Premix Ex TaqTM II (Takara, Dalian, Liaoning,
China) according to the manufacturer’s instructions.
Each 20 μl reaction buffer contained 10 μlo f2 × S Y B R
Premix Ex TaqTM II, 0.8 μl of primers at 10 μM, 2 μl
of diluted cDNA template, and 6.4 μlo fd d H 2 O .T h e
PCR conditions were 95°C for 5 sec and 60°C for 30 sec,
for 40 cycles. The primers for Actb (gene for beta-actin)
were: forward, 5’-CCT CTA TGC CAA CAC AGT GC-
3’ and reverse, 5’-GTA CTC CTG CTT GCT GAT CC-
3’; Ntrk1 (gene for trkA): forward, 5’-ATA TCT AGC
CAG CCT GCA CTT TGT-3’ and reverse, 5’-TGC
T C AT G CC A AA G TC T CC A - 3 ’;a n dNgfr (gene for
p75NTR): forward, 5’-TAT AGA CTC CTT TAC CCA
CG-3’ and reverse, 5’-AAT GTC AGC TCT CTG GAT
G-3’. The relative mRNA levels of Ntrk1 and Ngfr were
calculated and normalized against the level of Actb.
Statistics
All data were analyzed by SAS 6.12 (SAS institute Inc,
Cary, NC, USA) and expressed as mean ± SD. The
results of wesrern blot and gene expression were sub-
jected to one-way ANOVA. The results of uterine and
body weight were subjected to t-tests to compare the
mean value. A value of P < 0.05 was considered to be
statistically significant.
Results
Adenomyosis model of ICR mice
All mice dosed with tamoxifen developed adenomyosis in
this study. None of the controls had adenomyosis nodes in
the uteri (Figure 1A). The depth and area of ectopic endo-
metrium were increased as age increased for tamoxifen
dosed mice (Figure 1B-E). Nodules of endometrial glands
and stroma were present deep within the myometrium,
sometimes extending to, but not penetrating, the serosa.
Unilateral uterine weight and body weight for both dosing
mice and controls is shown in Table 1. For tamoxifen
dosed mice, at first, their uteri were lighter (90 ± 5 d,
P < 0.05) and then they became heavier (190 ± 5 d, 240 ±
5 d; P < 0.05) than those in controls.
Immunochemical localization of NGF-b, trkA and p75NTR
in the uterus
We performed immunohistochemical and immunofluor-
escence analysis to analyze the temporal and spatial
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the uterus. In the uteri of both adenomyosis and control
mice, NGF-b immunoreactivity was predominantly
observed in the luminal epithelial cells, glandular cells, and
stromal cells of the endometrium. NGF-b immunohisto-
chemical positive signals were scarce in myometrial cells
(Figure 2A-E). Immunoreactivity of p75NTR was detected
mainly in endometrial stromal cells (Figure 2F-J). Immu-
noreactivity of trkA was detected in nerve fibers distribu-
ted in the uterus (Figure 2K). Additionally, trkA was also
weakly expressed in luminal epithelial cells and glandular
cells in the endometrium (Figure 2L). The ectopic
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Figure 1 HE staining of paraffin-embedded sections. A: Uterus of 140 ± 5 d ICR mice as control. B:Uterus of 90 ± 5 d ICR mice with biopsy
confirmed adenomyosis; C: Uterus of 140 ± 5 d ICR mice with biopsy confirmed adenomyosis; D: Uterus of 190 ± 5 d ICR mice with biopsy
confirmed adenomyosis; E: Uterus of 240 ± 5 d ICR mice with biopsy confirmed adenomyosis; (L, luminal epithelium; G, glandular epithelium; S,
stromal cell; M, myometrium cell; arrows, ectopic endometrium; Bar = 50μm).
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location as eutopic endometrium.
Western blot analysis of NGF-b, proNGF and its receptors
in the uterus
The protein levels of NGF (13 kDa) and its precursors
(proNGF, 27 kDa), p75NTR (75 kDa) and trkA (145 kDa),
in the uteri of adenomyosis and control mice were detected
by western bolts (Figure 3). NGF, pro NGF, p75NTR and
trkA levels increased in the uteri of adenomyosis mice as
age increased (190 ± 5 d and 240 ± 5 d, P < 0.05, compared
with 90 ± 5 d) and remained unchanged in controls. The
expressions of NGF, its precursors and receptors of adeno-
myosis mice were higher than those in controls in the
1 9 0±5a n d2 4 0±5da g eg r o u p s( P<0 . 0 5 ) .
Gene expression of trkA and p75NTR in the DRG
The mRNA expressions of Ntrk1 (gene of trkA) and
Ngfr ( g e n eo fp 7 5 N T R )i nD R Go fa d e n o m y o s i sa n d
control ICR mice in the different age groups were exam-
ined by real time RT-PCR. Ntrk1 levels were signifi-
cantly increased in adenomyosis mice compared with
those in controls (190 ± 5 d and 240 ± 5 d, P < 0.05).
Ntrk1 levels increased as age increased in adenomyosis
mice (190 ± 5 d and 240 ± 5 d, P < 0.05, compared
with 90 ± 5 d). The mRNA levels of Ngfr were not dif-
ferent between adenomyosis and control mice and
remained stable as age increased (Figure 4).
Discussion
In this study, we investigated the expression of NGF and
its receptors (p75NTR and trkA) in the uterus and DRG
of mice with adenomyosis. A mouse model with pro-
gressively worsening adenomyosis was generated to
study the relationship between the expression of NGF
and the severity of adenomyosis. We showed that NGF-
b, p75NTR and trkA protein levels in uteri and trkA
mRNA levels in DRG were higher than those in con-
trols, while they gradually increased as adenomyosis
worsened.
We used tamoxifen administration to create the ade-
nomyosis mouse model. The precise mechanism for this
mouse model has not been fully clarified. It is proposed
that paracrine signaling prevents differentiation of uter-
ine myocytes in the mesenchyme, and over a period of
time this may permit downgrowth of the endometrium
into the myometrium [16]. In previous studies, the area
and depth of the ectopic endometrium in uteri of an
adenomyosis mouse model constantly increased as age
increased [17,31]. In the present study, we showed a
progressively infiltrated endometrium (Figure 1) and
increased uterine weight (Table 1) in adenomyosis mice.
In mice administered with tamoxifen, initially their uteri
were lighter, which might have been the result of depau-
perate mesenchyme [17] and then they became heavier,
which might have been because of ectopic endometrium
proliferation [2], comparedw i t hc o n t r o l s .W ec h o s e
four progressive age groups to represent four stages of
adenomyosis.
In the present study, immunoreactivity of NGF-b was
predominantly detected in the luminal and glandular
epithelial cells, and stromal cells of the endometrium.
We observed p75NTR mainly in stromal cells of the
endometrium and trkA in nerve fibers as well as in
luminal and glandular epithelial cells. The immunoloca-
tion of NGF-b, p75NTR and trkA in the ectopic endo-
metrium was similar to eutopic endometrium in
adenomyosis mice. Our finding of NGF’sl o c a t i o ni s
consistent with previous studies [32]. However, beside
nerve fibers [12,15], we also found p75NTR and trkA
immunostaining in endometrial cells. The expression of
NGF and its receptors in functional cells of the uterus
suggests a local effect, except for the well known effect
in the nervous system.
We examined the abnormal increase of NGF and its
receptors in uteri of adenomyosis mice by western blot.
NGF-b, p75NTR and trkA protein levels in uteri gradu-
ally increased while age increased in adenomyosis mice,
but they remained unchanged in control mice. In adeno-
myosis mice, as age increases, the disease progresses
[17,31]. Therefore, NGF can be used as an indicator for
the severity of adenomyosis. As a multi-functional cyto-
kine and growth factor, over expression of NGF might
exert an effect in multiple different ways. NGF is crucial
for the development of sympathetic and small fiber sen-
sory neurons that serve as nociceptors [6,7]. For adeno-
myosis, which also has an increased density of nerve
fibers in the uterus of symptomatic patients [33], NGF
might have the contribution to this abnormal innerva-
tion. NGF plays a crucial role in the generation of pain
and hyperalgesia in several acute and chronic pain states
[34,35]. NGF increases the excitability of primary affer-
ents by altering ion channels or neurotransmitter pro-
duction [36-38]. As a chemoattractant for granulocytes
Table 1 The unilateral uterine weight and body weigh of
adnomyosis and control ICR mice
Group Age (d) Uterine weight (mg) Body weight (g)
Control 90 ± 5 227.6 ± 23.5 43.80 ± 2.35
140 ± 5 227.8 ± 17.2 43.32 ± 2.62
190 ± 5 215 ± 9.76 45.98 ± 2.92
240 ± 5 223.8 ± 24.2 44.17 ± 3.12
Adenomyosis 90 ± 5 174.8 ± 14.8* 42.78 ± 2.49
140 ± 5 206.0 ± 21.0 47.84 ± 3.21
190 ± 5 243.3 ± 21.6* 49.68 ± 3.50
240 ± 5 243.0 ± 27.0* 45.84 ± 5.11
MEAN ± SD; n = 5; *P < 0.05 compared with the control group.
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stimulates the degranulation of mast cells, which helps
the release of pain-producing substances [39]. Therefore
we speculate that this ever-increasing NGF effect in
severe adenomyosis might contribute to the aggressive
pain accompanied by this disease. NGF also has a rela-
tionship with uterine weight and participates in stress-
triggered and substance P-mediated abortion [28,30].
These findings might be important for studies on ade-
nomyosis-related hysterauxesis and spontaneous
abortion.
The antibody we used for NGF-b (13 kD) can bind to
proNGF (27 kD). As a precursor, proNGF reflected the
reserve of mature NGF-b [40]. Pro-NGF can bind
A
J
I H G
F E D
C B
L K
Figure 2 Immunostaining of NGF-b, p75NTR and trkA in uteri of ICR mice with adenomyosis or not. A: Uterus of 140 ± 5 d control ICR
mice stained for NGF-b. B-E: Immnostaining of NGF-b in uterus of 90 ± 5 d, 140 ± 5 d, 190 ± 5 d and 240 ± 5 d ICR mice with adenomyosis,
respectively. F: Uterus of 140 ± 5 d control ICR mice stained for p75NTR. G-J: Immnostaining of p75NTR in uterus of 90 ± 5 d, 140 ± 5 d, 190 ± 5
d and 240 ± 5 d ICR mice with adenomyosis, respectively. K-L: trkA immnoreactivity was detected in nerve fibers (K; arrows, nerve fibers), luminal
and glandular epithelial cells of endometrium (L) in uterus of adenomyosis ICR mice aged 140 ± 5 d. (Bar = 100 μm).
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[40,41]. In peripheral inflammation, pro-NGF is up-
regulated and it plays a crucial role in inflammatory
hypersensitivity [40]. Our findings regarding the increase
of proNGF suggest that there is an abundant NGF-b
store and that is has a biological effect on hypersensitiv-
ity in inflammation.
We observed that p75NTR was strongly expressed in
endometrial stromal cells and weakly expressed in DRG,
while trkA was strongly expressed in uterine nerve fibers
and DRG but it was poorly expressed in luminal and
glandular epithelial cells. These findings suggest that the
stronger expression of p75NTR in the endometrium
enables NGF to have a local effect on stromal cells of
the uterus, while trkA might enable NGF to affect the
peripheral and central nervous system. NGF could be
taken up by nerve terminals and transferred to the cen-
tral nervous system to exert its effect. We detected
mRNA levels of NGF receptors but not NGF itself in
DRG, which is not unexpected because NGF is not
synthesized in this tissue [6].
The reason for the increase in NGF and its receptors
in adenomyosis mice is unclear. The level of NGF-b and
its receptors was mostly normal in tamoxifen adminis-
t e r e dm i c ea tt h ea g e so f9 0±5da n d1 4 0±5df o r
which ectopic endometrium was observed in the myo-
metrium. This suggests that the abnormal expression of
NGF-b is only an association but not the cause of ade-
nomyosis. Estrogen promotes the expression of NGF in
endometrium [42]. Adenomyosis has been shown to be
an estrogen-dependent disease that has abnormal local
estrogen production in the uterus [43,44]. Therefore,
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Figure 3 Western-blot analysis of NGF-b, pro NGF, p75NTR and trkA in adenomyosis (Ad) and control (Co) ICR mice uteri.
A: Representative Western-blot analysis of NGF-b, pro NGF, p75NTR and trkA in adenmoysis and control mice in different age groups. B:
Densitometirc analysis of NGF-b, pro NGF, p75NTR and trkA in adenomyosis and control mice in different age groups expressed as a percentage
after actin, beta normalization (n = 5; a = 90 ± 5 d, b = 150 ± 5 d, c = 190 ± 5 d, d = 240 ± 5d; *P < 0.05, compared with the control mice
with the same ages; #P < 0.05, compared with the 90 ± 5 d mice with the same treatment).
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the increase in NGF. It has also been reported that NGF
is associated with a variety of autoimmune and inflam-
matory diseases (e.g. allergic diseases and asthma
[45,46], and intestinal mucosa inflammation [47]) in
which elevated NGF levels correlate well with the sever-
ity of the diseases. It is well known that adenomyosis is
accompanied by various autoimmune phenomena in
humans. For example, patients with adenomyosis have
an increased number of macrophages, gamma delta
T cells in ectopic and eutopic endometrium, and
elevated preinflammatory factors and cytokines (e.g.
TNF-a, IL-10, and IL-18) in the uterus and peritoneal
fluid [29,48,49]. The augmentation of NGF might be the
result of inflammatory status and then mediate and/or
regulate the immune response. Therefore, we speculate
that with the infiltration and growth of ectopic endome-
trium, uterine inflammation and local estrogen synthesis
are increased, which could promote NGF synthesis.
NGF might then participate in neural plasticity, local
inflammation and production of pain. Therefore, it is
possible that NGF might be one of the important factors
that participate in the pathological mechanism of adeno-
myosis. In addition, it is worth mentioning that western
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Figure 4 mRNA expression of Ntrk1 and Ngfr in DRGs of adenomyosis (Ad) and control (Co) mice. A: the mRNA level of Ntrk1 in DRGs of
adenomyosis and control mice for different age groups. B: the Ngfr level in DRGs of adenomyosis and control mice for different age groups. (n
= 4; *P < 0.05, compared with the control mice with the same ages; #P < 0.05, compared with the 90 ± 5 d mice with the same treatment).
Li et al. Reproductive Biology and Endocrinology 2011, 9:30
http://www.rbej.com/content/9/1/30
Page 8 of 10blot and RT-PCR were performed from the whole
uterus in this study. However, endometrial glandular,
stromal, and myometrial components may differ in the
expression of NGF and its receptors as the data of
immunohistochemistry showed. So the increase of endo-
metrial glandular and stromal in adenomyosis might
affect the expression of NGF and receptors, too.
In the present study, we evaluated the expression of
NGF, p75NTR and trkA in uteri and DRG of adeno-
myosis mice. The protein levels of NGF and its recep-
tors in uteri and trkA mRNA levels in DRG were higher
in adenomyosis mice compared with those in controls,
and these levels increased with the severity of disease.
Recently, a novel class of pain drugs that are based on
antagonism of NGF have been investigated with a pro-
mising outcome [50]. Our results also suggest the possi-
bility of anti-NGF therapy for curing adenomyosis pain;
however, further study is required to determine this
issue.
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